Abiopharma

Bernhard Olivier 🟢 acquired 65.0K shares of On Holding AG (ONON) at $30.67 ($2.0M) Transaction Date: Aug 14, 2026 | Filing ID: 000006

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001918704-26-023863 <b>Size:</b> 423 KB

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001839882-26-040145 <b>Size:</b> 511 KB

Clinical trial NCT07106970 updates: 1. completion date: 2028-04-30 → 2028-08-30 2. primary completion date: 2027-09-30 → 2027-12-30

Clinical trial NCT06945250: completion date: 2026-10-01 → 2027-01-01.

Clinical trial NCT03654833 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-10-31 → 2024-03-15 3. primary completion date: 2023-10-31 → 2023-02-21

Clinical trial NCT07504601: start date: 2026-08-19 → 2026-08-20.

Clinical trial NCT06935266 updates: 1. completion date: 2025-09-22 → 2025-09-27 2. primary completion date: 2025-09-22 → 2025-09-27

Clinical trial NCT06745323 updates: 1. completion date: 2029-02-09 → 2029-05-10 2. primary completion date: 2029-02-09 → 2029-05-10

Clinical trial NCT07707466 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-08-31 → 2026-07-31 3. primary completion date: 2026-08-31 → 2026-07-31

Clinical trial NCT06042751 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-31 → 2026-05-27 3. primary completion date: 2026-01-31 → 2026-05-10 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07255807 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-12-01 → 2026-01-09

Clinical trial NCT06487559 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-10-01 → 2027-02-01 3. primary completion date: 2027-10-01 → 2027-02-01 4. enrollment: 20 → 3 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07549490: start date: 2026-08-19 → 2026-08-20.

Clinical trial NCT06205602: status: RECRUITING → ACTIVE_NOT_RECRUITING.